Literature DB >> 33594475

The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation.

Andrew P McGovern1,2, Nick J Thomas1,2, Sebastian J Vollmer3,4, Andrew T Hattersley1,2, Bilal A Mateen3,5, John M Dennis6.   

Abstract

Entities:  

Keywords:  COVID-19; Death; Diabetes; Vaccination

Mesh：

Substances：

Year:  2021        PMID： 33594475      PMCID： PMC7885981          DOI： 10.1007/s00125-021-05404-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  8 in total

1.  Use of "normal" risk to improve understanding of dangers of covid-19.

Authors:  David Spiegelhalter
Journal:  BMJ       Date:  2020-09-09

2.  Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.

Authors:  Bertrand Cariou; Samy Hadjadj; Matthieu Wargny; Matthieu Pichelin; Abdallah Al-Salameh; Ingrid Allix; Coralie Amadou; Gwénaëlle Arnault; Florence Baudoux; Bernard Bauduceau; Sophie Borot; Muriel Bourgeon-Ghittori; Olivier Bourron; David Boutoille; France Cazenave-Roblot; Claude Chaumeil; Emmanuel Cosson; Sandrine Coudol; Patrice Darmon; Emmanuel Disse; Amélie Ducet-Boiffard; Bénédicte Gaborit; Michael Joubert; Véronique Kerlan; Bruno Laviolle; Lucien Marchand; Laurent Meyer; Louis Potier; Gaëtan Prevost; Jean-Pierre Riveline; René Robert; Pierre-Jean Saulnier; Ariane Sultan; Jean-François Thébaut; Charles Thivolet; Blandine Tramunt; Camille Vatier; Ronan Roussel; Jean-François Gautier; Pierre Gourdy
Journal:  Diabetologia       Date:  2020-05-29       Impact factor: 10.122

3.  Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.

Authors:  Stuart J McGurnaghan; Amanda Weir; Jen Bishop; Sharon Kennedy; Luke A K Blackbourn; David A McAllister; Sharon Hutchinson; Thomas M Caparrotta; Joseph Mellor; Anita Jeyam; Joseph E O'Reilly; Sarah H Wild; Sara Hatam; Andreas Höhn; Marco Colombo; Chris Robertson; Nazir Lone; Janet Murray; Elaine Butterly; John Petrie; Brian Kennon; Rory McCrimmon; Robert Lindsay; Ewan Pearson; Naveed Sattar; John McKnight; Sam Philip; Andrew Collier; Jim McMenamin; Alison Smith-Palmer; David Goldberg; Paul M McKeigue; Helen M Colhoun
Journal:  Lancet Diabetes Endocrinol       Date:  2020-12-23       Impact factor: 32.069

4.  How old are you, really? Communicating chronic risk through 'effective age' of your body and organs.

Authors:  David Spiegelhalter
Journal:  BMC Med Inform Decis Mak       Date:  2016-08-05       Impact factor: 2.796

5.  Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study.

Authors:  Emma Barron; Chirag Bakhai; Partha Kar; Andy Weaver; Dominique Bradley; Hassan Ismail; Peter Knighton; Naomi Holman; Kamlesh Khunti; Naveed Sattar; Nicholas J Wareham; Bob Young; Jonathan Valabhji
Journal:  Lancet Diabetes Endocrinol       Date:  2020-08-13       Impact factor: 32.069

6.  Factors associated with COVID-19-related death using OpenSAFELY.

Authors:  Elizabeth J Williamson; Alex J Walker; Krishnan Bhaskaran; Seb Bacon; Chris Bates; Caroline E Morton; Helen J Curtis; Amir Mehrkar; David Evans; Peter Inglesby; Jonathan Cockburn; Helen I McDonald; Brian MacKenna; Laurie Tomlinson; Ian J Douglas; Christopher T Rentsch; Rohini Mathur; Angel Y S Wong; Richard Grieve; David Harrison; Harriet Forbes; Anna Schultze; Richard Croker; John Parry; Frank Hester; Sam Harper; Rafael Perera; Stephen J W Evans; Liam Smeeth; Ben Goldacre
Journal:  Nature       Date:  2020-07-08       Impact factor: 49.962

7.  Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.

Authors:  Ash K Clift; Carol A C Coupland; Ruth H Keogh; Karla Diaz-Ordaz; Elizabeth Williamson; Ewen M Harrison; Andrew Hayward; Harry Hemingway; Peter Horby; Nisha Mehta; Jonathan Benger; Kamlesh Khunti; David Spiegelhalter; Aziz Sheikh; Jonathan Valabhji; Ronan A Lyons; John Robson; Malcolm G Semple; Frank Kee; Peter Johnson; Susan Jebb; Tony Williams; Julia Hippisley-Cox
Journal:  BMJ       Date:  2020-10-20

8.  Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.

Authors:  Naomi Holman; Peter Knighton; Partha Kar; Jackie O'Keefe; Matt Curley; Andy Weaver; Emma Barron; Chirag Bakhai; Kamlesh Khunti; Nicholas J Wareham; Naveed Sattar; Bob Young; Jonathan Valabhji
Journal:  Lancet Diabetes Endocrinol       Date:  2020-08-13       Impact factor: 32.069
  8 in total
  6 in total

1.  COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study.

Authors:  Mario J Valladares-Garrido; Sandra Zeña-Ñañez; C Ichiro Peralta; Jacqueline B Puicón-Suárez; Cristian Díaz-Vélez; Virgilio E Failoc-Rojas
Journal:  Vaccines (Basel)       Date:  2022-05-20

2.  Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry.

Authors:  Norbert Stefan; Katrin Sippel; Martin Heni; Andreas Fritsche; Robert Wagner; Carolin E M Jakob; Hubert Preißl; Alexander von Werder; Yascha Khodamoradi; Stefan Borgmann; Maria Madeleine Rüthrich; Frank Hanses; Martina Haselberger; Christiane Piepel; Martin Hower; Jürgen Vom Dahl; Kai Wille; Christoph Römmele; Janne Vehreschild; Melanie Stecher; Michele Solimena; Michael Roden; Annette Schürmann; Baptist Gallwitz; Martin Hrabe de Angelis; David S Ludwig; Matthias B Schulze; Bjoern Erik Ole Jensen; Andreas L Birkenfeld
Journal:  Front Med (Lausanne)       Date:  2022-05-11

3.  COVID-19 vaccination in adolescents and young adults with type 1 diabetes: Glycemic control and side effects.

Authors:  Barbara Piccini; Benedetta Pessina; Francesco Pezzoli; Emilio Casalini; Sonia Toni
Journal:  Pediatr Diabetes       Date:  2022-03-02       Impact factor: 3.409

4.  Hepatic-Metabolite-Based Intermittent Fasting Enables a Sustained Reduction in Insulin Resistance in Type 2 Diabetes and Metabolic Syndrome.

Authors:  Markus Rohner; Robert Heiz; Simon Feldhaus; Stefan R Bornstein
Journal:  Horm Metab Res       Date:  2021-06-30       Impact factor: 2.936

Review 5.  COVID-19 and metabolic disease: mechanisms and clinical management.

Authors:  Charlotte Steenblock; Peter E H Schwarz; Barbara Ludwig; Andreas Linkermann; Paul Zimmet; Konstantin Kulebyakin; Vsevolod A Tkachuk; Alexander G Markov; Hendrik Lehnert; Martin Hrabě de Angelis; Hannes Rietzsch; Roman N Rodionov; Kamlesh Khunti; David Hopkins; Andreas L Birkenfeld; Bernhard Boehm; Richard I G Holt; Jay S Skyler; J Hans DeVries; Eric Renard; Robert H Eckel; K George M M Alberti; Bruno Geloneze; Juliana C Chan; Jean Claude Mbanya; Henry C Onyegbutulem; Ambady Ramachandran; Abdul Basit; Mohamed Hassanein; Gavin Bewick; Giatgen A Spinas; Felix Beuschlein; Rüdiger Landgraf; Francesco Rubino; Geltrude Mingrone; Stefan R Bornstein
Journal:  Lancet Diabetes Endocrinol       Date:  2021-10-04       Impact factor: 32.069

6.  Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States.

Authors:  Fan Lv; Xu Gao; Amy Huaishiuan Huang; Jian Zu; Xinyuan He; Xiaodan Sun; Jinli Liu; Ning Gao; Yang Jiao; Margaret G Keane; Lei Zhang; Yee Hui Yeo; Youfa Wang; Fanpu Ji
Journal:  EClinicalMedicine       Date:  2022-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.